Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium versus cisatracurium for QT interval changes during cataract surgery
IRCT20120215009014N441Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cataract comparing Atracurium with Cisatracurium (2 arms). Primary endpoint: QT interval. Started Sep 2022; status: completed.
02
Drugs
atracuriumcisatracurium
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20120215009014N441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N441.